Loading…

HFE hemochromatosis screening in patients with severe hip osteoarthritis: A prospective cross-sectional study

Despite the high frequency of HFE gene mutations in Western Europe, widespread screening for HFE hemochromatosis is not recommended due to its variable phenotype. Joint pain and a premature osteoarthritis-like disease including the hip joints are the most frequent manifestation in patients with HFE...

Full description

Saved in:
Bibliographic Details
Published in:PloS one 2018-11, Vol.13 (11), p.e0207415-e0207415
Main Authors: Oppl, Bastian, Husar-Memmer, Emma, Pfefferkorn, Svea, Blank, Martha, Zenz, Peter, Gollob, Eva, Wurnig, Christian, Engel, Alfred, Stadlmayr, Andreas, Uyanik, Gökhan, Brozek, Wolfgang, Klaushofer, Klaus, Zwerina, Jochen, Datz, Christian
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Despite the high frequency of HFE gene mutations in Western Europe, widespread screening for HFE hemochromatosis is not recommended due to its variable phenotype. Joint pain and a premature osteoarthritis-like disease including the hip joints are the most frequent manifestation in patients with HFE hemochromatosis and iron overload. Therefore, screening of patients with severe osteoarthritis of the hip could identify patients with HFE hemochromatosis. In this prospective cross-sectional study, 940 patients aged
ISSN:1932-6203
1932-6203
DOI:10.1371/journal.pone.0207415